» Articles » PMID: 27542972

Information Topics of Greatest Interest for Return of Genome Sequencing Results Among Women Diagnosed with Breast Cancer at a Young Age

Overview
Journal J Genet Couns
Publisher Wiley
Specialty Genetics
Date 2016 Aug 21
PMID 27542972
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated what information women diagnosed with breast cancer at a young age would want to learn when genome sequencing results are returned. We conducted 60 semi-structured interviews with women diagnosed with breast cancer at age 40 or younger. We examined what specific information participants would want to learn across result types and for each type of result, as well as how much information they would want. Genome sequencing was not offered to participants as part of the study. Two coders independently coded interview transcripts; analysis was conducted using NVivo10. Across result types, participants wanted to learn about health implications, risk and prevalence in quantitative terms, causes of variants, and causes of diseases. Participants wanted to learn actionable information for variants affecting risk of preventable or treatable disease, medication response, and carrier status. The amount of desired information differed for variants affecting risk of unpreventable or untreatable disease, with uncertain significance, and not health-related. Women diagnosed with breast cancer at a young age recognize the value of genome sequencing results in identifying potential causes and effective treatments and expressed interest in using the information to help relatives and to further understand their other health risks. Our findings can inform the development of effective feedback strategies for genome sequencing that meet patients' information needs and preferences.

Citing Articles

Associations between subjective social status and predictors of interest in genetic testing among women diagnosed with breast cancer at a young age.

Odumegwu J, Chavez-Yenter D, Goodman M, Kaphingst K Cancer Causes Control. 2024; 35(8):1201-1212.

PMID: 38700724 DOI: 10.1007/s10552-024-01878-0.


Assessing patient readiness for personalized genomic medicine.

Frost C, Andrulis I, Buys S, Hopper J, John E, Terry M J Community Genet. 2018; 10(1):109-120.

PMID: 29804257 PMC: 6325047. DOI: 10.1007/s12687-018-0365-5.


How do providers discuss the results of pediatric exome sequencing with families?.

Walser S, Werner-Lin A, Mueller R, Miller V, Biswas S, Bernhardt B Per Med. 2017; 14(5):409-422.

PMID: 28966657 PMC: 5616214. DOI: 10.2217/pme-2017-0015.

References
1.
Kaphingst K, McBride C, Wade C, Hensley Alford S, Brody L, Baxevanis A . Consumers' use of web-based information and their decisions about multiplex genetic susceptibility testing. J Med Internet Res. 2010; 12(3):e41. PMC: 2956320. DOI: 10.2196/jmir.1587. View

2.
Hitch K, Joseph G, Guiltinan J, Kianmahd J, Youngblom J, Blanco A . Lynch syndrome patients' views of and preferences for return of results following whole exome sequencing. J Genet Couns. 2014; 23(4):539-51. PMC: 4451087. DOI: 10.1007/s10897-014-9687-6. View

3.
Schmidlen T, Wawak L, Kasper R, Garcia-Espana J, Christman M, Gordon E . Personalized genomic results: analysis of informational needs. J Genet Couns. 2014; 23(4):578-87. DOI: 10.1007/s10897-014-9693-8. View

4.
Sharp R . Downsizing genomic medicine: approaching the ethical complexity of whole-genome sequencing by starting small. Genet Med. 2011; 13(3):191-4. DOI: 10.1097/GIM.0b013e31820f603f. View

5.
Anders C, Hsu D, Broadwater G, Acharya C, Foekens J, Zhang Y . Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008; 26(20):3324-30. DOI: 10.1200/JCO.2007.14.2471. View